Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,177
archived clinical trials in
Orthopedic

Comparison of DISCOVER™ Artificial Cervical Disc and ACDF for Treatment of Cervical DDD (IDE Study)
A Multi-Center, Prospective, Randomized Controlled Trial Comparing Cervical Arthroplasty to Anterior Cervical Discectomy and Fusion for the Treatment of Cervical Degenerative Disc Disease
Status: Enrolling
Updated:  9/19/2017
Pacific Private Clinic
mi
from 43215
Queensland,
Comparison of DISCOVER™ Artificial Cervical Disc and ACDF for Treatment of Cervical DDD (IDE Study)
A Multi-Center, Prospective, Randomized Controlled Trial Comparing Cervical Arthroplasty to Anterior Cervical Discectomy and Fusion for the Treatment of Cervical Degenerative Disc Disease
Status: Enrolling
Updated: 9/19/2017
Pacific Private Clinic
mi
from 43215
Queensland,
Click here to add this to my saved trials
Anesthesia and Motor Evoked Potential (MEP) Recruitment
The Effect of Anesthesia on the Recruitment of Motor Evoked Potentials Using an Increased Number of Pulses
Status: Enrolling
Updated:  9/19/2017
Cincinnati Children's Hospital Medical Center
97
mi
from 43215
Cincinnati, OH
Anesthesia and Motor Evoked Potential (MEP) Recruitment
The Effect of Anesthesia on the Recruitment of Motor Evoked Potentials Using an Increased Number of Pulses
Status: Enrolling
Updated: 9/19/2017
Cincinnati Children's Hospital Medical Center
97
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Liposomal Bupivacaine With Bupivacaine in Ankle Fracture Open Reduction Internal Fixation (ORIF)
The Impact of Liposomal Bupivicaine on Post-Operative Pain in Orthopaedic Trauma Surgery: A Double-Blind Prospective Randomized Control Trial
Status: Enrolling
Updated:  9/19/2017
Jamaica Hospital Medical Center
486
mi
from 43215
Jamaica, NY
Liposomal Bupivacaine With Bupivacaine in Ankle Fracture Open Reduction Internal Fixation (ORIF)
The Impact of Liposomal Bupivicaine on Post-Operative Pain in Orthopaedic Trauma Surgery: A Double-Blind Prospective Randomized Control Trial
Status: Enrolling
Updated: 9/19/2017
Jamaica Hospital Medical Center
486
mi
from 43215
Jamaica, NY
Click here to add this to my saved trials
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated:  9/20/2017
City of Hope Comprehensive Cancer Center
1955
mi
from 43215
Duarte, CA
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated: 9/20/2017
City of Hope Comprehensive Cancer Center
1955
mi
from 43215
Duarte, CA
Click here to add this to my saved trials
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated:  9/20/2017
University of Kansas Cancer Center and Medical Pavilion
620
mi
from 43215
Westwood, KA
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated: 9/20/2017
University of Kansas Cancer Center and Medical Pavilion
620
mi
from 43215
Westwood, KA
Click here to add this to my saved trials
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated:  9/20/2017
Dana-Farber Cancer Institute
643
mi
from 43215
Boston, MA
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated: 9/20/2017
Dana-Farber Cancer Institute
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated:  9/20/2017
Memorial Sloan Kettering Cancer Center
480
mi
from 43215
New York, NY
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated: 9/20/2017
Memorial Sloan Kettering Cancer Center
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated:  9/20/2017
Duke Cancer Center
354
mi
from 43215
Durham, NC
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated: 9/20/2017
Duke Cancer Center
354
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated:  9/20/2017
Ohio State University
2
mi
from 43215
Columbus, OH
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated: 9/20/2017
Ohio State University
2
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated:  9/20/2017
Oregon Health and Science University
2026
mi
from 43215
Portland, OR
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated: 9/20/2017
Oregon Health and Science University
2026
mi
from 43215
Portland, OR
Click here to add this to my saved trials
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated:  9/20/2017
Washington University School of Medicine
397
mi
from 43215
Saint Louis, MO
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated: 9/20/2017
Washington University School of Medicine
397
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated:  9/20/2017
Hackensack University Medical Center - John Theurer Cancer Center
476
mi
from 43215
Hackensack, NJ
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated: 9/20/2017
Hackensack University Medical Center - John Theurer Cancer Center
476
mi
from 43215
Hackensack, NJ
Click here to add this to my saved trials
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated:  9/20/2017
Huntsman Cancer Center, University of Utah
1511
mi
from 43215
Salt Lake City, UT
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated: 9/20/2017
Huntsman Cancer Center, University of Utah
1511
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated:  9/20/2017
Centre Hospitalier Universitaire de Grenoble
4292
mi
from 43215
La Tronche,
Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease
Status: Enrolling
Updated: 9/20/2017
Centre Hospitalier Universitaire de Grenoble
4292
mi
from 43215
La Tronche,
Click here to add this to my saved trials
Tranexamic Acid Use in Acute Hip Fractures
The Use of Tranexamic Acid to Reduce the Need for Transfusion 1 Week Post-operatively for Hemiarthroplasty or Intramedullary Nailing Needed to Correct Acute Hip Fractures
Status: Enrolling
Updated:  9/20/2017
Carilion Roanoke Memorial Hospital
248
mi
from 43215
Roanoke, VA
Tranexamic Acid Use in Acute Hip Fractures
The Use of Tranexamic Acid to Reduce the Need for Transfusion 1 Week Post-operatively for Hemiarthroplasty or Intramedullary Nailing Needed to Correct Acute Hip Fractures
Status: Enrolling
Updated: 9/20/2017
Carilion Roanoke Memorial Hospital
248
mi
from 43215
Roanoke, VA
Click here to add this to my saved trials
BOTOX® (Onabotulinumtoxin A) Injection(s) as a Treatment for Carpal Tunnel Syndrome
BOTOX® (Onabotulinumtoxin A) Injection(s) as a Treatment for Carpal Tunnel Syndrome
Status: Enrolling
Updated:  9/22/2017
Arizona Arthritis & Rheumatology
1654
mi
from 43215
Phoenix, AZ
BOTOX® (Onabotulinumtoxin A) Injection(s) as a Treatment for Carpal Tunnel Syndrome
BOTOX® (Onabotulinumtoxin A) Injection(s) as a Treatment for Carpal Tunnel Syndrome
Status: Enrolling
Updated: 9/22/2017
Arizona Arthritis & Rheumatology
1654
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Rush University Medical Center
277
mi
from 43215
Chicago, IL
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Rush University Medical Center
277
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Johns Hopkins University
343
mi
from 43215
Baltimore, MD
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Johns Hopkins University
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Ohio State University
2
mi
from 43215
Columbus, OH
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Ohio State University
2
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Oregon Health and Science University
2026
mi
from 43215
Portland, OR
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Oregon Health and Science University
2026
mi
from 43215
Portland, OR
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Avera Hematology & Transplant Center
747
mi
from 43215
Sioux Falls, SD
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Avera Hematology & Transplant Center
747
mi
from 43215
Sioux Falls, SD
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Texas Transplant Institute
1138
mi
from 43215
San Antonio, TX
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Texas Transplant Institute
1138
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Fred Hutchinson Cancer Research Center
2007
mi
from 43215
Seattle, WA
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Fred Hutchinson Cancer Research Center
2007
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
City of Hope National Medical Center
1955
mi
from 43215
Duarte, CA
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
City of Hope National Medical Center
1955
mi
from 43215
Duarte, CA
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
University of California, San Diego Medical Center
1926
mi
from 43215
La Jolla, CA
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
University of California, San Diego Medical Center
1926
mi
from 43215
La Jolla, CA
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Stanford Hospital and Clinics
2100
mi
from 43215
Stanford, CA
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Stanford Hospital and Clinics
2100
mi
from 43215
Stanford, CA
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Colorado Blood Cancer Institute
1161
mi
from 43215
Denver, CO
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Colorado Blood Cancer Institute
1161
mi
from 43215
Denver, CO
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
University of Florida College of Medicine
714
mi
from 43215
Gainesville, FL
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
University of Florida College of Medicine
714
mi
from 43215
Gainesville, FL
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
BMT Program at Northside Hospital
427
mi
from 43215
Atlanta, GA
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
BMT Program at Northside Hospital
427
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Ann & Robert Lurie Children's Hospital of Chicago
274
mi
from 43215
Chicago, IL
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Ann & Robert Lurie Children's Hospital of Chicago
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Indiana BMT at Beech Grove
163
mi
from 43215
Beech Grove, IN
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Indiana BMT at Beech Grove
163
mi
from 43215
Beech Grove, IN
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
University of Iowa Hospitals and Clinics
460
mi
from 43215
Iowa City, IA
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
University of Iowa Hospitals and Clinics
460
mi
from 43215
Iowa City, IA
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
University of Maryland Medical Systems
343
mi
from 43215
Baltimore, MD
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
University of Maryland Medical Systems
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Tufts Medical Center
642
mi
from 43215
Boston, MA
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Tufts Medical Center
642
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
DFCI, Massachusetts General Hospital
643
mi
from 43215
Boston, MA
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
DFCI, Massachusetts General Hospital
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Dana-Farber Cancer Institute/Brigham & Women's Hospital
643
mi
from 43215
Boston, MA
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Dana-Farber Cancer Institute/Brigham & Women's Hospital
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
University of Michigan Medical Center
161
mi
from 43215
Ann Arbor, MI
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
University of Michigan Medical Center
161
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Univ of Minnesota
624
mi
from 43215
Minneapolis, MN
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Univ of Minnesota
624
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
The Mayo Clinic
559
mi
from 43215
Rochester, MN
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
The Mayo Clinic
559
mi
from 43215
Rochester, MN
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Hackensack University Medical Center
476
mi
from 43215
Hackensack, NJ
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Hackensack University Medical Center
476
mi
from 43215
Hackensack, NJ
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Memorial Sloan Kettering Cancer Center
480
mi
from 43215
New York, NY
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Memorial Sloan Kettering Cancer Center
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Weill Cornell Medical College NY Presbyterian Hospital
480
mi
from 43215
New York, NY
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Weill Cornell Medical College NY Presbyterian Hospital
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
University of North Carolina Hospital at Chapel Hill
344
mi
from 43215
Chapel Hill, NC
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
University of North Carolina Hospital at Chapel Hill
344
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
University of Pennsylvania Cancer Center
414
mi
from 43215
Philadelphia, PA
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
University of Pennsylvania Cancer Center
414
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Medical University of South Carolina
524
mi
from 43215
Charleston, SC
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Medical University of South Carolina
524
mi
from 43215
Charleston, SC
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Baylor University Medical Center
910
mi
from 43215
Dallas, TX
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Baylor University Medical Center
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
University of Texas MD Anderson Cancer Research Center
995
mi
from 43215
Houston, TX
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
University of Texas MD Anderson Cancer Research Center
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Virginia Commonwealth University
344
mi
from 43215
Richmond, VA
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Virginia Commonwealth University
344
mi
from 43215
Richmond, VA
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated:  9/27/2017
Medical College of Wisconsin
330
mi
from 43215
Milwaukee, WI
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
Status: Enrolling
Updated: 9/27/2017
Medical College of Wisconsin
330
mi
from 43215
Milwaukee, WI
Click here to add this to my saved trials